Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.65%
#2 Victoria VR Victoria VR +11.02%
#3 Palladium Network Palladium Network +8.55%
#4 Cryptopia Cryptopia +4.36%
#5 COTI COTI +3.80%
#6 GRVT Token GRVT Token +2.92%
#7 Lisk Lisk +2.64%
#8 NEAR Intents Bridged ZEC NEAR Intents Bridged ZEC +2.61%
#9 Kinetiq Kinetiq +2.57%
#10 Lighter Lighter +2.56%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Xeno Transplants Corporation Xeno Transplants Corporation

Xeno Transplants Corporation

XENO
Rangering i aksjer #42146
Xeno Transplants Corporation functions as a biotechnology firm dedicated to... Xeno Transplants Corporation functions as a biotechnology firm dedicated to research and development. Leveraging a specific licensing agreement with Massachusetts General Hospital, the company aims to innovate, produce, commercialize, and implement products and methodologies for public application in the field of xenotransplantation. The primary objective of this xenotransplantation research is to alleviate the critical scarcity of human cells, tissues, and organs required for medical transplants. This is achieved by pioneering techniques that enable the transfer of biological components—such as cells, tissues, and organs—from non-human species, including pigs, into human recipients. Established in 2004, Xeno Transplants Corporation maintains its headquarters in Brookline, Massachusetts.
Aksjekurs
$0.0001
Sist synkronisert: 2026-08-11
Markedsverdi
$4.04K
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
CA
Handel Xeno Transplants Corporation (XENO)

Kategori

Healthcare
Aksjeprishistorikk for Xeno Transplants Corporation (XENO)
Høyeste sluttskurs: $0.00 den 2026-08-01

Laveste sluttskurs: $0.33 den 2006-08-01
Aksjeprishistorikk for Xeno Transplants Corporation fra 2006 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) 0.00%
2025 0.00%
2024 0.00%
2023 -50.00%
2022 100.00%
2021 -93.74%
2020 -73.43%
2019 102.25%
2018 -7.07%
2017 67.54%
2016 -45.43%
2015 153.29%
2014 -23.64%
2013 -9.52%
2012 -44.74%
2011 -59.79%
2010 332.31%
2009 -85.91%
2008 -96.85%
2007 -72.30%
2006 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $527.87 33.33%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $873.57 35.10%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $736.38 7.69%
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $263.09 18.09%
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -7.57%
KR